| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Pseudoephedrine hydrochloride 60 mg oral tablet |
Is a |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Pseudoephedrine hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| pseudoephedrinhydrochlorid 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Pseudoephedrine hydrochloride 120mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 15 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/1 ml/4 mg/1 ml/25 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat 2 mg/1 ml + dextromethorphanhydrobromid 4 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat + pseudoephedrinhydrochlorid 4 mg/5 ml/60 mg/5 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat + pseudoephedrinhydrochlorid 2 mg/1 ml/25 mg/1 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat 2 mg/5 ml + pseudoephedrinhydrochlorid 30 mg/5 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat + pseudoephedrinhydrochlorid 8 mg/120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Cetirizine hydrochloride+pseudoephedrine hydrochloride 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| fexofenadinhydrochlorid + pseudoephedrinhydrochlorid 60 mg/120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/5 ml 10 mg/5 ml 30 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| brompheniraminmaleat 2 mg + hydrocodonhydrogentartrat 1,7 mg + pseudoephedrinhydrochlorid 30 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| cetirizinhydrochlorid + pseudoephedrin 5 mg/120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| chlorpheniraminmaleat 8 mg + methscopolaminnitrat 2,5 mg + pseudoephedrinhydrochlorid 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| codeinphosphat 10 mg + pseudoephedrinhydrochlorid 30 mg + triprolidinhydrochlorid 1,25 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Fexofenadine hydrochloride + pseudoephedrine hydrochloride 60mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 45 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| brompheniraminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 30 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml/12,5 mg/5 ml/60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 1 mg/1 ml/4 mg/1 ml/15 mg/1 ml dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat + pseudoephedrinhydrochlorid 1 mg/1 ml/15 mg/1 ml dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Ibuprofen+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| methscopolaminnitrat + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| pseudoephedrinhydrochlorid + terfenadin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| brompheniraminmaleat + hydrocodonhydrogentartrat + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| cetirizinhydrochlorid + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| carbinoxaminmaleat + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| codeinphosphat + pseudoephedrinhydrochlorid + triprolidinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| chlorpheniraminmaleat + methscopolaminnitrat + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Acrivastine+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| fexofenadinhydrochlorid + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| pseudoephedrinhydrochlorid 120 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| ibuprofen 200 mg + pseudoephedrin 30 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| ibuprofen 100 mg + pseudoephedrin 15 mg 5 ml oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| fexofenadinhydrochlorid 180 mg + pseudoephedrinhydrochlorid 240 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Chlorpheniramine maleate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| paracetamol + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| brompheniraminmaleat + pseudoephedrinhydrochlorid 16 mg/240 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| cetirizinhydrochlorid + pseudoephedrin 5 mg/120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Pseudoephedrine hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Pseudoephedrine hydrochloride 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely paracetamol 500 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Cetirizine hydrochloride + pseudoephedrine 5mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Pseudoephedrine hydrochloride 120mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Product containing precisely pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
| Pseudoephedrine hydrochloride 60 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pseudoephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
FHIR